Pluristem Will Present on the Value of Placental-derived Mesenchymal Stromal Cells in Wound Healing at the 10th Annual Wound Healing: Science and Industry Conference
HAIFA, ISRAEL, Dec. 10, 2009--Pluristem Therapeutics Inc. (NasdaqCM: PSTI; DAX: PJT) today announced that it will present at the 10th Annual Wound Healing: Science and Industry conference at the Wyndham Sugar Bay Resort and Spa in St. Thomas, U.S. Virgin Islands. William R. Prather R.Ph., M.D., senior vice president of corporate development at Pluristem, will present on the value of placental-derived mesenchymal stromal cells in wound healing at 8:10 a.m. Atlantic Standard Time, Friday, Dec. 11, 2009.
“We are excited that Pluristem is able to present information on their innovative placental-derived stromal cell technology and its role in angiogenesis and wound healing.” said Peter Sheehan, M.D., program chairman of the 10th Annual Wound Healing: Science and Industry conference.
The 10th Annual Wound Healing: Science and Industry conference is collaboration between academia and industry in presenting topics that may have immediate impact on the field of wound care. Topics have been selected by the program committee based on research developments and emerging trends.
|
